Observatoire européen des drogues et des toxicomanies, & Commission interaméricaine de lutte contre l'abus des drogues de l'Organisation des États américains (Eds.). (2010). Création d'un observatoire national des drogues : manuel conjoint. Joint publications. Luxembourg: Office des publications officielles des Communautés européennes.
Abstract: National drugs observatories have flourished and developed rapidly over the last two decades as a direct consequence of the decisions taken to establish regional drug monitoring systems, both in the European Union and in the Americas. Initially, there was no reference framework available — observatories were set-up using trial and error, taking into account different national contexts and resources. This explains why today there are as many models of observatories as there are countries establishing them. Looking back at this long process, there seemed to be a need to formalise the experiences in the field, and to identify some key concepts and principles that remain valid irrespective of country or region. This handbook, a joint production by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Inter-American Drug Abuse Control Commission of the Organization of American States (CICAD–OAS), presents and describes in a clear and informative way the core operational processes and the key strategic factors that are common to all national drugs observatories.
Keywords: monitoring; drug; organizational structure; administration and management; Europe; Americas; international area
|
Organisation mondiale de la santé. (2010). Stratégie mondiale visant à réduire l'usage nocif de l'alcool. Genève: Organisation mondiale de la santé (OMS).
Keywords: government and politics; international area; alcohol; AOD public policy strategy
|
World Health Organization. (2010). Global strategy to reduce the harmful use of alcohol. Geneva: World Health Organization (WHO).
Keywords: government and politics; international area; alcohol; AOD public policy strategy
|
European Centre for Disease Prevention and Control, & European Monitoring Centre for Drugs and Drug Addiction. (2011). Prevention and control of infectious diseases among people who inject drugs. Stockholm: European Centre for Disease Prevention and Control (ECDC).
Keywords: prevention; prevention program; prevention directed at groups; illicit drug; infection; HIV infection; hepatitis B; hepatitis C; tuberculosis; hepatitis A; disease transmission factor; Europe; European Union
|
European Monitoring Centre for Drugs and Drug Addiction (Ed.). (2011). European drug prevention quality standards : a manual for prevention professionals. Manuals, 7. Luxembourg: Publications Office of the European Union.
Abstract: Prevention is one of the first approaches to be mentioned when public debate and policy address drug use and drug-related problems. Regularly, measures of prevention are presented as a means to overcome existing or future problems. However, evidence of ‘what works’ in practice is often overlooked. Similarly, research has shown examples where preventive efforts produced no or detrimental effects. This publication will help steer efforts in the right direction. Using an empirically derived reference framework, it bridges the gaps between science, policy and practice. Based on an overview of existing standards in Europe and beyond, a number of highly respected experts from EU Member States and international organisations worked together to prepare the publication. More than 400 national experts and stakeholders were included in a Delphi panel study and in a number of focus groups, which produced in-depth discussions as well as a consensus on the most important recommendations. The European Commission provided the funding for the original project on prevention standards and its results are now published within the EMCDDA Manuals series. In this series, information, advice, and guidance are offered to professionals and practitioners. Well structured and with many useful tables and figures, this publication will help its users as they progress from a first needs assessment to the delivery of an intervention and its final evaluation. Correct implementation of prevention measures with evidence-based components and anchoring them within existing structures and services (or activities) is key to ensuring effectiveness and it helps to avoid unintended iatrogenic effects. This manual will provide valuable guidance in this respect and allow preventive interventions to reach their full potential.
Keywords: AOD use, abuse, and dependence; prevention program; prevention; prevention strategy; quality; quality control; international area; Europe
|
various. (2012). Guidelines for the evaluation of drug prevention : a manual for programme planners and evaluators (European Monitoring Centre for Drugs and Drug Addiction, Ed.) (2nd ed.). Manuals, 8. Luxembourg: Office for Official Publications of the European Communities.
Abstract: Prevention is a key consideration when discussing substance use and related problems. Drug prevention is any activity that delays or reduces the use of substances. Preventing substance use potentially makes other interventions, especially targeting treatment and harm reduction, unnecessary. Evaluation of the various interventions is essential to develop and improve existing approaches and to work towards creating a best practice in drug prevention. The EMCDDA first published the Guidelines for the evaluation of drug prevention in 1998 to respond to a need expressed by professionals and policymakers to have a tool and stimulus to evaluate prevention interventions in Europe. These guidelines aimed to facilitate and encourage project leaders to evaluate their own interventions and to design them accordingly. This second edition is an updated version of the original EMCDDA guidelines, which contains new methods, concepts and examples of currently available drug prevention interventions and which provides a framework for carrying out an evaluation. The content has also been updated with developments in online EMCDDA drug prevention and evaluation resources. Since publication of the first edition, prevention professionals who continue to apply these guidelines have contributed to the increased attention given to evaluation and prevention. However, although guidance on drug prevention is available in some Member States, only a minority of interventions in the European Union have an outcome evaluation. Even large, wellfunded projects are still not fully evaluated and the availability of empirical evidence concerning prevention is weak. These guidelines are intended for professionals working in the drug prevention and evaluation field and can provide valuable guidance when planning and evaluating prevention activities. The intention to develop best practice in drug prevention, as expressed in the 2005–8 and 2009–12 EU drugs action plans, and the fact that evaluation is now widely used in Member States’ drug policy, testify to the importance placed on drug prevention and evaluation in the European Union. The aim of this publication is to raise the profile of both drug prevention and evaluation methodologies and to provide prevention practitioners with an up-to-date framework, to enable their interventions and evaluations to reach their full potential.
Keywords: AOD use, abuse, and dependence; research; prevention; prevention outcome; prevention research; prevention directed at groups; recommendations or guidelines; Europe
|
Acker, N., Drunecky, G., Grillich, L., Gruber, C., Haas, S., Kriener, H., et al. (2002). Evaluation : Forderungen & Anleitungen aus der Sicht von Suchtprävention und Drogenarbeit (Qualitätszirkel Evaluation, Ed.). Wien: Österreichisches Bundesinstitut für Gesundheitswesen (ÖBIG).
Keywords: evaluation; addiction; prevention; addiction care; treatment and maintenance; continuing education; financing; Austria
|
of England, D. of H., Government, T. S., Government, W. A., & Northern Ireland Executive. (2007). Drug misuse and dependence : guidelines on clinical management. London: Department of Health of England; The Scottish Government; Welsh Assembly Government; Northern Ireland Executive;.
Keywords: recommendations or guidelines; health care professionals; physician; social worker; pharmacist; AOD use, abuse, and dependence; AOD dependent; AOD user; intravenous drug user; patient; old age; elderly; adolescent; pregnancy; parent; AOD effects and AODR problems; infection; mental health; AODR mortality; harm reduction; intervention (persuasion to treatment); treatment and maintenance; inpatient care; hospital; drug therapy; opioids in any form; methadone maintenance; buprenorphine; naltrexone; benzodiazepines; licit drug; alcohol; tobacco in any form; law enforcement; criminal penalty; relapse prevention; AOD use and driving; international area; United Kingdom; drug substitution therapy
|
Dupont Pharma. (1996). Ein Leitfaden für Ärzte und Therapeuten : Nemexin : Naltrexonhydrochlorid : auf dem Weg aus der Drogenabhängigkeit. Bad Homburg: Author.
Keywords: treatment and maintenance
|
Hubbard, R. L. (1985). La purification : une réponse illustrée au problèmes de drogues. Copenhague: New Era.
Keywords: treatment and maintenance; outpatient care
|
